In 2017, the Gates Foundation adopted the goal of administering contraceptives to 214 million women in poor countries.69 Gates’s contraceptive of choice is the long-term infertility agent Depo-Provera. Population planners have administered Depo-Provera primarily to poor and Black women in the United States since its invention in 1967. In the United States, 84 percent of Depo-Provera users are Black, and 74 percent are low-income.70 Depo-Provera’s biggest promoter, Planned Parenthood, specifically targets Blacks71 and Latinas72 in its marketing campaigns. UN data demonstrate that Depo-Provera
...more
This highlight has been truncated due to consecutive passage length restrictions.